EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Sundry Debtors History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹88 Cr | ₹100 Cr | ₹76 Cr | ₹69 Cr | ₹51 Cr |
What is the latest Sundry Debtors ratio of EVEREST ORGANICS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹88 Cr |
| Mar2024 | ₹100 Cr |
| Mar2023 | ₹76 Cr |
| Mar2022 | ₹69 Cr |
| Mar2021 | ₹51 Cr |
How is Sundry Debtors of EVEREST ORGANICS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹88 Cr | -11.64 | |
| Mar2024 | ₹100 Cr | 31.11 | |
| Mar2023 | ₹76 Cr | 11.33 | |
| Mar2022 | ₹69 Cr | 35.46 | |
| Mar2021 | ₹51 Cr | - | |
Compare Sundry Debtors of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹309.0 Cr | 6.9% | 0.3% | -6.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 6.9% |
0.3% |
-6.3% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses